Cigna Group stock trades near USD 275 as analysts stick with Moderate Buy consensus

Published on 09/20/2026 at 15:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cigna Group stock closed near USD 275 on September 19, 2026, leaving more than 20 percent upside to the average analyst price target around USD 337. Analysts see revenue up 6.7 percent in the latest quarter and expect full-year EPS above USD 30.

Modernes Bürogebäude eines US-Krankenversicherers mit Glasfassade und gepflegtem Außengelände — Cigna Group Krankenversicherung modernes Unternehmensgebäude mit Glasfassade, ISIN US1255231003, Mitarbeiter gehen zum Eingang, Illustration mit AI erstellt.

Cigna Group stock (ISIN US1255231003) stood around USD 275 on the New York Stock Exchange as of September 19, 2026, implying more than 20 percent upside to the average analyst price target near USD 337 and keeping valuation firmly in view for investors.

Analysts maintain Moderate Buy view with double-digit upside

According to MarketBeat on September 20, 2026, Cigna Group carries a consensus rating of Moderate Buy based on 23 analyst opinions, with 15 Buy and 8 Hold recommendations and no Sell ratings.

The same MarketBeat overview cites an average analyst price target of USD 337.10, which represents roughly 22 to 23 percent potential upside compared with a contemporaneous share price of USD 275.57 used in its dataset.MarketBeat

Additional valuation work compiled by Ad-hoc news based on Simply Wall St data and summarized on September 18, 2026 points to an average one-year analyst price target of about USD 340.50 across 24 analysts, with the highest individual target around USD 400 and the lowest near USD 290.

Latest quarterly figures show mid-single-digit revenue growth

Cigna Group last reported quarterly earnings on July 30, 2026 for its most recent quarter, giving investors an updated look at the health services provider’s operating momentum.MarketBeat

As reported by MarketBeat, Cigna Group delivered earnings per share of USD 7.78 in that quarter, beating the analysts’ consensus estimate of USD 7.60 by USD 0.18.

Quarterly revenue reached USD 70.04 billion for the period, compared with analyst expectations of USD 70.14 billion, and rose 6.7 percent from the same quarter a year earlier when the company recorded USD 7.20 in EPS.MarketBeat

Net margin stood at 2.27 percent in the quarter, while return on equity reached 19.75 percent, underscoring the company’s ability to generate profits on its capital base in a competitive health insurance and services environment.MarketBeat

Looking ahead, Cigna Group has set fiscal-year 2026 guidance at EPS of 30.450 and sell-side analysts surveyed by MarketBeat expect full-year EPS of about 30.51, suggesting that the company’s earnings trajectory remains broadly aligned with management’s outlook.MarketBeat

Dividend and cash returns add to the investment case

Cigna Group also returns cash to shareholders through a regular dividend, which enhances the total return profile for investors focusing on income.

The company recently declared a quarterly dividend of USD 1.56 per share, corresponding to an annualized dividend of USD 6.24 and a yield of around 2.3 percent at the share price level cited in the MarketBeat data.MarketBeat

MarketBeat notes that Cigna Group’s payout ratio stands at 25.82 percent, leaving room for the company to pursue growth investments and potential share repurchases while maintaining its dividend program.MarketBeat

Stock trades near mid-USD 270s with sizable gap to targets

Per an overview published on September 19, 2026, Cigna Group stock traded in the mid-USD 270s on the New York Stock Exchange, with a specific closing level of USD 275.28 and an intraday range between USD 273.74 and USD 276.15 in the latest session.Ad-hoc news

MarketBeat data referenced by that summary shows that Cigna Group’s market capitalization is about USD 72.77 billion and that the stock trades on a trailing price-to-earnings ratio of 11.39, underlining the valuation gap between current pricing and the analyst consensus targets above USD 330.Ad-hoc news

According to pricing information compiled by Reuters as of September 19, 2026, The Cigna Group shares last changed hands at USD 275.58, down 0.12 percent on the day, with a daily trading range between USD 274.12 and USD 277.43.

The same Reuters overview lists a 52-week trading range for Cigna Group stock between USD 239.65 and USD 314.45, placing the latest price roughly in the upper half of that band and about 12.4 percent below the 52-week high.Reuters

Regulatory backdrop and ACA exit add a risk factor

Beyond the numbers, the regulatory environment and Cigna Group’s strategic decisions in health insurance markets remain a key factor for investors to watch.

As reported by NewsBreak on September 19, 2026, Cigna has told regulators and investors that it is exiting the Affordable Care Act individual market entirely, both on and off exchange, in each of the 11 states where it currently sells ACA plans.

This exit from ACA marketplaces could alter Cigna Group’s revenue mix and competitive positioning over time, reducing exposure to certain individual segments while potentially increasing the focus on employer-sponsored health plans, Medicare-related offerings and other health service lines where profitability may be more attractive.

For shareholders, the combination of solid recent earnings growth, a relatively low trailing price-to-earnings ratio, a dividend yield above 2 percent and a strategic shift away from ACA individual markets creates a complex risk-reward profile that analysts currently summarize with a Moderate Buy stance and price targets well above the latest share price.

Stock price and market data as of latest session

Cigna Group stock closed at USD 275.58 on the New York Stock Exchange as of September 19, 2026, based on data compiled by Reuters, with a modest daily decline of 0.12 percent and an intraday range between USD 274.12 and USD 277.43 in that session.